ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION

Victrex plc

LSE:VCT 株式レポート

時価総額:UK£843.8m

  • 会社概要
    • 評価
    • 将来の成長
    • 過去の実績
    • 財務の健全性
    • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

Victrex マネジメント

マネジメント 基準チェック /14

Victrexの CEO はJames Routhで、 Jan2026年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.042%を直接所有しており、その価値は£ 351.34K 。経営陣と取締役会の平均在任期間はそれぞれ0.3年と3.5年です。

主要情報

James Routh

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.04%
経営陣の平均在職期間less than a year
取締役会の平均在任期間3.5yrs

経営陣の近況

Recent updates

User avatar
ナラティブ更新 • Sep 09

VCT: Profit Improvement Plan And Leadership Transition Will Shape Future Re Rating

Analysts have raised their price target on Victrex from £8.49 to £9.70, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations. What’s in the News for Victrex Victrex appointed Chris Gilbert as Interim Chief Financial Officer, effective 1 September 2026, with experience at Elementis plc and Deloitte LLP, according to company disclosures.
User avatar
ナラティブ更新 • Jun 22

VCT: Margin Progress And Lower P/E Framework Will Support Future Re Rating

Analysts have nudged their Victrex price target slightly lower to £8.49 from £8.51, citing updated assumptions around revenue growth, profit margins and future P/E expectations that leave the overall valuation broadly unchanged. What's in the News No recent Victrex specific news items or key developments were available from the provided sources.
User avatar
ナラティブ更新 • Jun 05

VCT: Updated Discount Rate And P E Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples that slightly reshape the company’s risk and return profile. What's in the News No recent company specific news for Victrex has been provided in the available sources.
User avatar
ナラティブ更新 • May 21

VCT: Margin Execution And Lower P/E Framework Will Support Future Re Rating

Analysts have trimmed their implied price target on Victrex by about £0.39, citing updated assumptions around profit margins, revenue growth and a lower future P/E multiple following recent Street research. Analyst Commentary Street research around Victrex has shifted to a more cautious stance on valuation, with the latest move being a £1.00 cut to the implied price target from JPMorgan.
User avatar
ナラティブ更新 • May 01

VCT: Cautious P E And Discount Rate Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. These changes modestly adjust their outlook on the shares.
User avatar
ナラティブ更新 • Apr 17

VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating

Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.
User avatar
ナラティブ更新 • Apr 03

VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
User avatar
ナラティブ更新 • Mar 19

VCT: Future Upside Will Be Anchored By Resilient Earnings Framework

Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.
User avatar
ナラティブ更新 • Mar 05

VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions

Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
User avatar
ナラティブ更新 • Feb 19

VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity

Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.
User avatar
ナラティブ更新 • Feb 05

VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential

Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.
分析記事 • Jan 27

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
ナラティブ更新 • Jan 22

VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating

Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.
分析記事 • Jan 09

Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend of £0.4614 per share on the 27th of...
User avatar
ナラティブ更新 • Jan 08

VCT: Future Upside Will Be Driven By Resilient Earnings Power

Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.
User avatar
ナラティブ更新 • Dec 24

VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential

Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.
分析記事 • Dec 24

Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend on the 27th of February, with investors...
User avatar
ナラティブ更新 • Dec 10

VCT: Future Upside Will Be Driven By Medical Volume Rebound

Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.
分析記事 • Dec 10

We Like The Quality Of Victrex's (LON:VCT) Earnings

Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...
分析記事 • Dec 05

Victrex (LON:VCT) Has Announced A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...
User avatar
ナラティブ更新 • Nov 26

VCT: Future Recovery Will Be Driven By Medical Volume Rebound

Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.
User avatar
ナラティブ更新 • Nov 11

VCT: Future Leadership Transition Will Guide Recovery As Margins Improve

Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.
分析記事 • Oct 11

Market Participants Recognise Victrex plc's (LON:VCT) Earnings

When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...
分析記事 • Jun 28

Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
分析記事 • May 19

We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative

The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...
分析記事 • May 15

Victrex's (LON:VCT) Dividend Will Be £0.1342

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.1342 per share on 27th of June. This makes the...
User avatar
新しいナラティブ • May 12

China Plant And Magma Programme Will Expand Market Reach

Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.
分析記事 • Apr 08

With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For

Victrex plc ( LON:VCT ) shareholders that were waiting for something to happen have been dealt a blow with a 31% share...
分析記事 • Mar 24

Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...
分析記事 • Feb 26

Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?

Key Insights Victrex's estimated fair value is UK£18.18 based on 2 Stage Free Cash Flow to Equity Victrex's UK£9.32...
分析記事 • Jan 15

Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 21st of February. Based on this payment, the dividend...
分析記事 • Dec 06

Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Victrex plc ( LON:VCT ) shareholders would be excited to see that the share price has had a great month, posting a 25...
分析記事 • Sep 13

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Aug 03

Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price

With a price-to-earnings (or "P/E") ratio of 29.8x Victrex plc ( LON:VCT ) may be sending very bearish signals at the...
分析記事 • Jul 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Jun 14

There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
分析記事 • May 27

Calculating The Fair Value Of Victrex plc (LON:VCT)

Key Insights Victrex's estimated fair value is UK£14.70 based on 2 Stage Free Cash Flow to Equity With UK£12.96 share...
分析記事 • Mar 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Feb 24

Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
分析記事 • Jan 12

Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Victrex plc ( LON:VCT ) filed its annual result this time last week. The early...
分析記事 • Dec 08

Victrex (LON:VCT) Will Pay A Dividend Of £0.4614

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.4614 per share on 23rd of February. This means...
分析記事 • Nov 23

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
分析記事 • Oct 19

Is Victrex plc (LON:VCT) Trading At A 22% Discount?

Key Insights Victrex's estimated fair value is UK£17.25 based on 2 Stage Free Cash Flow to Equity Victrex's UK£13.47...

CEO

James Routh (53 yo)

less than a year
在職期間

Dr. James Mathew Routh, Ph D., is Chief Executive Officer & Executive Director of Victrex plc from January 1, 2026. Dr. Routh serves as Senior Independent Non-Executive Director of Tracsis plc since Septem...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
James Routh
CEO & Executive Directorless than a yearデータなし0.042%
£ 351.3k
Chris Gilbert
Interim Chief Financial Officerno dataデータなしデータなし
Jilly Atherton
Group Human Resource Directorno dataデータなしデータなし
John Devine
Managing Director for Medical3yrsデータなしデータなし
Daniel Diffenderfer
Managing Director of Medicalless than a yearデータなしデータなし
Andrew Ng
Chief Commercial Officerless than a yearデータなしデータなし
0.3yrs
平均在職期間

経験豊富な経営陣: VCTの経営陣は 経験豊富 とはみなされません ( 0.3年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
James Routh
CEO & Executive Directorless than a yearデータなし0.042%
£ 351.3k
Dame Cox
Independent Non-Executive Chair4.8yrsUK£280.00k0.0080%
£ 67.4k
Peter Kiernan
Non-Executive Directorless than a yearデータなしデータなし
Maria Antoniou
Non-Executive Directorno dataデータなしデータなし
Brendan Wynne Connolly
Independent Non-Executive Director8.6yrsUK£68.00k0.0021%
£ 17.7k
Janet Ashdown
Independent Non-Executive Director8.6yrsUK£70.50k0.0036%
£ 30.5k
Rosalind Rivaz
Senior Independent Director6.3yrsUK£69.40k0.0022%
£ 18.9k
Urmi Richardson
Independent Non-Executive Director2.3yrsUK£58.50k0.00011%
£ 928.1
3.5yrs
平均在職期間
66.5yo
平均年齢

経験豊富なボード: VCTの 取締役会 は 経験豊富 であると考えられます ( 3.5年の平均在任期間)。


企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/18 03:28
終値2026/09/18 00:00
収益2026/03/31
年間収益2025/09/30

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Victrex plc 11 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。28

アナリスト機関
James StewartBarclays
Katie RichardsBarclays
Gunther ZechmannBarclays

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド